Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-06
DOI
10.1038/s41598-018-24337-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
- (2017) Min Li et al. Molecular Medicine Reports
- KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
- (2017) Guido Eibl et al. SEMINARS IN CANCER BIOLOGY
- Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice
- (2017) Hui-Hua Chang et al. PLoS One
- Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis
- (2016) S Amin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Transforming Cancer Prevention through Precision Medicine and Immune-oncology
- (2016) T. W. Kensler et al. Cancer Prevention Research
- Cancer Prevention and Interception: A New Era for Chemopreventive Approaches
- (2016) A. Albini et al. CLINICAL CANCER RESEARCH
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
- (2016) Roongruedee Chaiteerakij et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin increases hepatic leptin receptor and decreases steatosis in mice
- (2016) Xuemei Tang et al. JOURNAL OF ENDOCRINOLOGY
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Regulation of TAZ in cancer
- (2016) Xin Zhou et al. Protein & Cell
- An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression
- (2015) H. Hayashi et al. CANCER RESEARCH
- (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
- (2015) M. Reni et al. CLINICAL CANCER RESEARCH
- Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms
- (2015) Vincenza Cifarelli et al. DIABETES
- Cancer Prevention: Obstacles, Challenges, and the Road Ahead
- (2015) Frank L. Meyskens et al. JNCI-Journal of the National Cancer Institute
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
- (2015) Xiang-Lin Tan et al. PANCREAS
- Cancer Prevention: Obstacles, Challenges, and the Road Ahead
- (2015) Frank L. Meyskens et al. JNCI-Journal of the National Cancer Institute
- Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
- (2015) Joao Incio et al. PLoS One
- The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes
- (2014) I. C. Lega et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Metformin and Cancer: Mounting Evidence Against an Association: Figure 1
- (2014) Samy Suissa et al. DIABETES CARE
- Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
- (2014) Shih-Lung Woo et al. PLoS One
- Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells
- (2014) Ming Ming et al. PLoS One
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Effects of metformin on weight loss
- (2014) Steven K. Malin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells
- (2014) Enrique Rozengurt Frontiers in Physiology
- High-Fat, High-Calorie Diet Promotes Early Pancreatic Neoplasia in the Conditional KrasG12D Mouse Model
- (2013) D. W. Dawson et al. Cancer Prevention Research
- AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
- (2013) Graeme J. Gowans et al. Cell Metabolism
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- Metformin Inhibits the Growth of Human Pancreatic Cancer Xenografts
- (2013) Krisztina Kisfalvi et al. PANCREAS
- Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
- (2013) Heloisa P. Soares et al. PLoS One
- Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK
- (2012) James Sinnett-Smith et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition
- (2012) Wei Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Metformin in the Management of NAFLD
- (2011) Angela Mazza et al. Experimental Diabetes Research
- Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms
- (2011) Paige M. Bracci MOLECULAR CARCINOGENESIS
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCPE3 Ligase
- (2010) Chen-Ying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
- (2010) C Algire et al. ONCOGENE
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
- (2009) K. Kisfalvi et al. CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now